MRRSE has announced the addition of the “Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020” report to their offering.

1. Cervical Cancer Diagnostic Tests Market - Complete Study of
Current Trends and Forecast For 2020
Report Description
Cervical cancer is a medical condition in which cells present
in the lining of the cervix - gradually develop into pre-
cancerous mass of cells that ultimately turn into cancerous

2. tumors. Two major types of cervical cancers that are typically
screened and diagnosed in women include adenocarcinoma
and squamous cell carcinoma. At the same time, it has been
observed that approximately 90% cases of cervical cancers are
squamous cell carcinoma. Virtually, almost all the cases of
cervical cancer cases are due to specific types of human
papillomavirus and there are more than 100 different types of
HPV virus present, of which nearly 40 are sexually
transmitted. Among these, about 15 different types HPV
viruses are considered as high-risk type or cancer causing.
Today, cervical cancer is recognized to be one of the most
common types of cancers affecting U.S. women and ranks
14th in frequency. Worldwide, cervical cancer is the third
most common cancer among women and the second most

3. frequent cause of cancer-related death, accounting for almost
300,000 deaths annually.
This research report provides a detailed analysis of the global
cervical cancer diagnostic tests market and helps in
understanding the various driving factors for the growth of
the market. The market overview section analyzes market
dynamics and trends such as drivers, restraints and
opportunities that influence the current nature and future
status of the market. The executive summary provides
detailed insights about the report and the market in general.
It also contains a market snapshot, which provides a glimpse
into the present scenario of the global cervical cancer
diagnostic tests market. Impact factors such as market

4. attractiveness analysis and Porter’s five forces analysis have
also been explained in the market overview section of the
report in order to deliver a thorough analysis of the overall
competitive scenario of the global cervical cancer diagnostic
tests market.
Request For Sample Copy Of Report @ https://goo.gl/JdHa4o
The global cervical cancer diagnostic tests market is
segmented based on types of tests performed for the
diagnosis of cancer patients. Based on the test types, the
market is segmented into Pap smear tests, HPV testing,
colposcopy, endocervical curettage procedure and others,

5. which comprise cone biopsy and Loop Electrosurgical Excision
Procedure (LEEP). Market size estimates and forecasts for the
period 2012 to 2020 have been provided for each of the
segments mentioned above in terms of USD million,
considering 2013 as the base year for calculating market
forecast and 2012 as the historical year. The CAGR (%) of
each market segment for the forecast period 2014 to 2020
has also been provided along with market size estimations.
Geographically, the global cervical cancer diagnostic tests
market has been segmented into four major regional markets:
North America, Europe, Asia Pacific and Rest of World
(RoW). The market size estimations and forecasts for the
period 2012 to 2020 have been provided for each of these

6. regions at a segment level, in terms of USD million along
with the CAGR for the forecast period 2014 to 2020. This
study further offers market recommendations for the global
cervical cancer diagnostic tests market. These include factors
that may play a critical role in enhancing or boosting the
market in the near future, as well as steps that need to be
considered to ensure success for manufacturers.
Inquiry for Check discount @
http://www.mrrse.com/checkdiscount/1381
The report concludes with the company profiles section and
includes key information about the major players who are
actively participating in this market. The company profiles

7. included in the report are framed in terms of company
overview, financial overview, business strategies, recent
developments and product portfolio. Key players profiled in
this report include Abbott Laboratories, Becton, Dickinson
and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd.,
Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico
Ltd., Guided Therapeutics, Inc., OncoHealth Corp.,
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
sources thousands of industry reports, market statistics, and

8. company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.
Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207

9. United States
Tel: +1-518-730-0559
Email: sales@mrrse.com